1. Sandhoff Disease: Defective Glycosaminoglycan Catabolism in Cultured Fibroblasts and Its Correction by β-<em>N</em>-Acetylhexosaminidase.
- Author
-
Cantz, Michael, Kreese, Hans, and Reiss-Husson, Françoise
- Subjects
- *
TAY-Sachs disease , *FIBROBLASTS , *CULTURES (Biology) , *GLYCOSAMINOGLYCANS , *SULFATES , *METABOLISM , *ISOENZYMES - Abstract
1. Fibroblasts cultured from the skin of patients with Sandhoff disease accumulate excessive amounts of sulfated glycosaminoglycans, probably chondroitin sulfate and dermatan sulfate. In addition, Sandhoff fibroblasts show a lengthened turnover time for these compounds. Only little such abnormality in sulfated glycosaminoglycan metabolism has been found in Tay-Sachs fibroblasts. 2. The impaired catabolism of glycosaminoglycans in Sandhoff fibroblasts can be normalized, i.e. corrected, by addition of β-N-acetylhexosaminidase isozyme A from normal human urine to the culture medium. β-N-Acetylhexosaminidase isozyme B from urine is ineffective because it is not taken up by the cells. However, if homogenates of normal or Tay-Sachs fibroblasts are used as a source of the enzymes, metabolic correction is obtained in both instances. When β-N-acetylhexosaminidase isozymes A and B of normal fibroblasts are separated by isoelectric focusing and tested individually, isozyme A exhibits about five times the corrective activity of isozyme B, when compared on the basis of their activity toward the synthetic substrate, 3. Although β-N-acetylhexosaminidase isozyme B participates in the degradation of sulfated glycosaminoglycans in cultured cells, only fibroblast homogenates containing isozyme A release N-acetylglucosamine from [14C]glucosamine-labelled hyaluronic acid oligosaccharides in vitro. [ABSTRACT FROM AUTHOR]
- Published
- 1974
- Full Text
- View/download PDF